Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays - PubMed (original) (raw)
Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays
Naoki Kagawa et al. Brain Tumor Pathol. 2006 Apr.
Abstract
Medulloblastoma (MB) is the most frequent infratentorial malignant brain tumor in children. In contrast, primitive neuroectodermal tumor (PNET) is defined as a supratentorial malignant tumor generated from the cerebral hemisphere. These tumors have considerable histological overlap but have different clinical outcomes including overall survival period, recurrence rate, and chemosensitivity. We investigated the amplification and/or deletion of genes and the chromosomal gain and/or loss in 10 MBs and 3 PNETs with a genomic DNA microarray system. Genes that are frequently amplified in these both these tumors include MSH2, N-myc, AKT3, and EGFR. Amplifications of SNRPN, MYB, and PTEN are observed only in MB. The genes associated with Wnt/APC and Shh/PTCH pathways also have some aberrations. Common chromosomal aberrations include gains at 17q and 7q and losses at 17p. Minor chromosomal losses were also detected at 1p, 8p + q, 11p, 10p + q, 13q, 16q, and Xp + q in MB. SPNETs tend to contain fewer chromosomal and genetic abnormalities than MBs. In conclusion, there are gene expression and chromosomal differences between MBs and SPNETs. These differences may correlate with the prognosis.
Similar articles
- MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, Phillips PC. Grotzer MA, et al. Clin Cancer Res. 2001 Aug;7(8):2425-33. Clin Cancer Res. 2001. PMID: 11489822 - Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH, Kim JH, Eun KM, Wang KC, Park KH, Choi SA, Kim YY, Park SH, Cho BK, Kim SK. Phi JH, et al. J Neurosurg Pediatr. 2010 Jun;5(6):608-14. doi: 10.3171/2010.2.PEDS1065. J Neurosurg Pediatr. 2010. PMID: 20515335 - Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA, Janss AJ, Raffel C, Sutton L, Rorke LB, Harper JM, Phillips PC. Biegel JA, et al. Clin Cancer Res. 1997 Mar;3(3):473-8. Clin Cancer Res. 1997. PMID: 9815707 - Cytogenetic and molecular genetic abnormalities in primitive neuroectodermal tumors of the central nervous system.
Goussia AC, Bruner JM, Kyritsis AP, Agnantis NJ, Fuller GN. Goussia AC, et al. Anticancer Res. 2000 Jan-Feb;20(1A):65-73. Anticancer Res. 2000. PMID: 10769636 Review. - [Molecular biological study of cerebellar medulloblastoma and supratentorial primitive neuroectodermal tumors].
Xuan Q, Xu QZ. Xuan Q, et al. Zhonghua Bing Li Xue Za Zhi. 2003 Jun;32(3):271-3. Zhonghua Bing Li Xue Za Zhi. 2003. PMID: 14518436 Review. Chinese. No abstract available.
Cited by
- Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.
Johnson H, Del Rosario AM, Bryson BD, Schroeder MA, Sarkaria JN, White FM. Johnson H, et al. Mol Cell Proteomics. 2012 Dec;11(12):1724-40. doi: 10.1074/mcp.M112.019984. Epub 2012 Sep 10. Mol Cell Proteomics. 2012. PMID: 22964225 Free PMC article. - Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer.
Ramalingam S, Ramamoorthy P, Subramaniam D, Anant S. Ramalingam S, et al. Immunogastroenterology. 2012;1(1):27-33. doi: 10.7178/ig.1.1.7. Immunogastroenterology. 2012. PMID: 23795348 Free PMC article. - Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors.
Pallavicini G, Berto GE, Di Cunto F. Pallavicini G, et al. Int J Mol Sci. 2019 Apr 28;20(9):2098. doi: 10.3390/ijms20092098. Int J Mol Sci. 2019. PMID: 31035417 Free PMC article. Review. - Pediatric brain tumors: current treatment strategies and future therapeutic approaches.
Mueller S, Chang S. Mueller S, et al. Neurotherapeutics. 2009 Jul;6(3):570-86. doi: 10.1016/j.nurt.2009.04.006. Neurotherapeutics. 2009. PMID: 19560746 Free PMC article. Review. - MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.
Tatevossian RG, Tang B, Dalton J, Forshew T, Lawson AR, Ma J, Neale G, Shurtleff SA, Bailey S, Gajjar A, Baker SJ, Sheer D, Ellison DW. Tatevossian RG, et al. Acta Neuropathol. 2010 Dec;120(6):731-43. doi: 10.1007/s00401-010-0763-1. Epub 2010 Nov 3. Acta Neuropathol. 2010. PMID: 21046410 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous